Abstract |
Rapamycin, a natural product inhibitor of the Raptor- mammalian target of rapamycin complex (mTORC1), is known to induce Protein kinase B (Akt/PKB) Ser-473 phosphorylation in a subset of human cancer cell lines through inactivation of S6K1, stabilization of insulin receptor substrate (IRS)-1, and increased signaling through the insulin/ insulin-like growth factor-I/ phosphatidylinositol 3-kinase (PI3K) axis. We report that A-443654, a potent small-molecule inhibitor of Akt serine/threonine kinases, induces Akt Ser-473 phosphorylation in all human cancer cell lines tested, including PTEN- and TSC2-deficient lines. This phenomenon is dose-dependent, manifests coincident with Akt inhibition and likely represents an alternative, rapid-feedback pathway that can be functionally dissociated from mTORC1 inhibition. Experiments performed in TSC2-/- cells indicate that TSC2 and IRS-1 cooperate with, but are dispensable for, A-443654-mediated Akt phosphorylation. This feedback event does require PI3K activity, however, as it can be inhibited by LY294002 or wortmannin. Small interfering RNA-mediated knockdown of mTOR or Rictor, components of the rapamycin-insensitive mTORC2 complex, but not the mTORC1 component Raptor, also inhibited Akt Ser-473 phosphorylation induced by A-443654. Our data thus indicate that Akt phosphorylation and activity are coupled in a manner not previously appreciated and provide a novel mode of Akt regulation that is distinct from the previously described rapamycin-induced IRS-1 stabilization mechanism.
|
Authors | E K-H Han, J D Leverson, T McGonigal, O J Shah, K W Woods, T Hunter, V L Giranda, Y Luo |
Journal | Oncogene
(Oncogene)
Vol. 26
Issue 38
Pg. 5655-61
(Aug 16 2007)
ISSN: 0950-9232 [Print] England |
PMID | 17334390
(Publication Type: Journal Article)
|
Chemical References |
- A 443654
- Chromones
- Enzyme Inhibitors
- Indazoles
- Indoles
- Morpholines
- Multiprotein Complexes
- Phosphoinositide-3 Kinase Inhibitors
- Proteins
- RNA, Small Interfering
- TSC2 protein, human
- Transcription Factors
- Tuberous Sclerosis Complex 2 Protein
- Tumor Suppressor Proteins
- 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
- Serine
- Mechanistic Target of Rapamycin Complex 1
- Proto-Oncogene Proteins c-akt
- TOR Serine-Threonine Kinases
|
Topics |
- Cell Line, Tumor
- Chromones
(pharmacology)
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(pharmacology)
- Humans
- Immunoblotting
- Indazoles
(pharmacology)
- Indoles
(pharmacology)
- Mechanistic Target of Rapamycin Complex 1
- Morpholines
(pharmacology)
- Multiprotein Complexes
- Mutation
- Phosphatidylinositol 3-Kinases
(metabolism)
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
(drug effects)
- Proteins
- Proto-Oncogene Proteins c-akt
(antagonists & inhibitors, metabolism)
- RNA, Small Interfering
(genetics)
- Serine
(metabolism)
- TOR Serine-Threonine Kinases
- Time Factors
- Transcription Factors
(genetics, metabolism)
- Transfection
- Tuberous Sclerosis Complex 2 Protein
- Tumor Suppressor Proteins
(genetics, metabolism)
|